Sign in
ACIU Stock Price, Chart, Stats & News
AC Immune S.A.
Save
235.10M
Market cap
–
Current P/E
11.24x
Forward P/E
ACIU chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 100.00% |
Operating margin | -1927.32% |
Pretax margin | -1971.65% |
Net margin | -1968.65% |
Effective tax rate | – |
ROA | -45.55% |
ROE | -101.60% |
D/E | 0.10x |
Interest coverage ratio | -472.70x |
ACIU valuation
P/E | – |
P/S | 61.40x |
P/B | 4.85x |
P/CF | -3.15x |
P/FCF | -3.13x |
P/OCF | -3.15x |
PEG | -0.04x |
EV multiple | -3.55x |
About
AC Immune S. A. is a biotech firm operating at the clinical stage, dedicated to pioneering, formulating, and advancing therapeutic agents and diagnostic tools. Its core mission is addressing neurodegenerative conditions rooted in protein misfolding, both preventatively and therapeutically.
Similar securities
Based on sector and market capitalization
Report issue